Clover Health Investments, Corp. (CLOV)

NASDAQ: CLOV · Real-Time Price · USD
2.620
+0.120 (4.80%)
At close: Aug 13, 2025, 4:00 PM
2.670
+0.050 (1.91%)
After-hours: Aug 13, 2025, 5:10 PM EDT
4.80%
Market Cap 1.34B
Revenue (ttm) 1.61B
Net Income (ttm) -43.10M
Shares Out 512.51M
EPS (ttm) -0.09
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 8,607,371
Open 2.540
Previous Close 2.500
Day's Range 2.505 - 2.670
52-Week Range 1.870 - 4.870
Beta 1.92
Analysts Strong Buy
Price Target 4.37 (+66.79%)
Earnings Date Aug 5, 2025

About CLOV

Clover Health Investments, Corp. provides medicare advantage plans in the United States. The company offers preferred provider organization and health maintenance organization plans to medicare-eligible individuals. It operates Clover Assistant, a software platform to execute strategy by enabling physicians to detect, identify, and manage chronic diseases earlier than they otherwise could. The company is based in Wilmington, Delaware. [Read more]

Sector Healthcare
Founded 2014
Employees 570
Stock Exchange NASDAQ
Ticker Symbol CLOV
Full Company Profile

Financial Performance

In 2024, Clover Health Investments's revenue was $1.37 billion, an increase of 8.52% compared to the previous year's $1.26 billion. Losses were -$43.01 million, -79.84% less than in 2023.

Financial Statements

Analyst Forecast

According to 3 analysts, the average rating for CLOV stock is "Strong Buy." The 12-month stock price target is $4.37, which is an increase of 66.79% from the latest price.

Price Target
$4.37
(66.79% upside)
Analyst Consensus: Strong Buy
Stock Forecasts

News

Clover Health: Short-Term Pain Hides Its Long-Term Profitability Potential

While Clover Health's Q2 earnings showed continued member and revenue growth, it dropped 30% since then due to higher medical costs that impacted all MA plan providers. Clover Health still maintains i...

2 days ago - Seeking Alpha

Clover Health Investments, Corp. (CLOV) Q2 2025 Earnings Call Transcript

Clover Health Investments, Corp. (NASDAQ:CLOV) Q2 2025 Earnings Conference Call August 5, 2025 5:00 PM ET Company Participants Andrew Toy - Co-Founder, CEO & Director Peter J. Kuipers - Chief Financi...

7 days ago - Seeking Alpha

Clover Health Reports Second Quarter 2025 Results; Delivering Strong Sustainable Growth

Second quarter 2025 Medicare Advantage membership of 106,323, up 32% year-over-year Second quarter 2025 Total revenues of $478 million, up 34% year-over-year Second quarter 2025 profitability metrics ...

8 days ago - GlobeNewsWire

Primary Care Physician Use of Counterpart Assistant Technology Linked to Better Health Outcomes in Patients with Chronic Obstructive Pulmonary Disease

New whitepaper shows that a relationship with a primary care physician (“PCP”) who uses Counterpart Assistant is correlated with more frequent Chronic Obstructive Pulmonary Disease (“COPD”) diagnosis,...

9 days ago - GlobeNewsWire

Clover Health Applauds White House and CMS' Push to “Tear Down Digital Walls,” Accelerating and Simplifying Access to Health Data for Patients and Their Clinicians

WILMINGTON, Del., July 31, 2025 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover Health”), a physician enablement company bringing access to great healthcare to everyone on...

13 days ago - GlobeNewsWire

Counterpart Health Appoints Vicky Bruner as Vice President of Operations to Support Expansion and Customer Execution

WILMINGTON, Del., July 29, 2025 (GLOBE NEWSWIRE) -- Counterpart Health, Inc. (“Counterpart”), a wholly owned subsidiary of Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or...

15 days ago - GlobeNewsWire

Clover Health to Participate in Upcoming Canaccord Genuity 45th Annual Growth Conference

WILMINGTON, Del., July 21, 2025 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), today announced that its Chief Financial Officer, Pete...

23 days ago - GlobeNewsWire

Clover Health Appoints Joseph Oldakowski as Vice President of Finance and Controller

WILMINGTON, Del., July 17, 2025 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover Health”), a physician enablement company bringing access to great healthcare to everyone on...

27 days ago - GlobeNewsWire

Clover Health Launches New Jersey Community Pharmacy Program in Partnership with IPC's iCare+ Network

WILMINGTON, Del., July 09, 2025 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover Health”), a leading Medicare Advantage company committed to affordable, high-quality care, ...

5 weeks ago - GlobeNewsWire

Clover Health to Report Second Quarter 2025 Financial Results on August 5, 2025

WILMINGTON, Del., July 08, 2025 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), today announced that it will release its financial res...

5 weeks ago - GlobeNewsWire

Clover Health Set to Join Russell 3000® Index

WILMINGTON, Del., June 30, 2025 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover Health”), announced that it is set to join the broad-market Russell 3000® Index, effective ...

6 weeks ago - GlobeNewsWire

Clover Health: Stars Are Aligning For GAAP Profitability In FY 2026

Clover reported impressive Q1 earnings with robust topline growth and improving profitability metrics thanks to a 30% YoY increase in its member base. Clover could see $95 million in additional revenu...

3 months ago - Seeking Alpha

Top 3 Health Care Stocks That Could Sink Your Portfolio In Q2

As of May 8, 2025, three stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.

Other symbols: ARDTHIMS
3 months ago - Benzinga

Clover Health Investments, Corp. (CLOV) Q1 2025 Earnings Call Transcript

Clover Health Investments, Corp. (NASDAQ:CLOV) Q1 2025 Earnings Conference Call May 6, 2025 5:00 PM ET Company Participants Ryan Schmidt - Investor Relations Andrew Toy - Chief Executive Officer Pete...

3 months ago - Seeking Alpha

Clover Health Reports First Quarter 2025 Results and Improves Full Year 2025 Guidance

First quarter 2025 Medicare Advantage membership of 103,418, up 30% year-over-year First quarter 2025 Total revenues of $462 million, up 33% year-over-year Medicare Advantage medical costs are in line...

3 months ago - GlobeNewsWire

Primary Care Physician Use of Counterpart Assistant Technology Associated with Better Health Outcomes in Patients with Congestive Heart Failure

New whitepaper highlights how a relationship with a Primary Care Physician (“PCP”) that uses Counterpart Assistant is associated with better clinical management, and fewer hospitalizations (18% lower)...

3 months ago - GlobeNewsWire

Clover Health Announces Changes to Board of Directors

Thomas L. Tran will become Chairman of the Audit Committee and the Nominating and Corporate Governance Committee, and Lee A. Shapiro will not stand for re-election at the 2025 Annual Shareholders' Mee...

4 months ago - GlobeNewsWire

Clover Health to Participate in Upcoming Investor Conferences

WILMINGTON, Del., April 21, 2025 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), today announced its participation in the following in...

4 months ago - GlobeNewsWire

Clover Health to Report First Quarter 2025 Financial Results on May 6, 2025

WILMINGTON, Del., April 08, 2025 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), today announced that it will report first quarter 202...

4 months ago - GlobeNewsWire

Clover Health Appoints Industry Veteran as Chief Medical Officer of Medicare Advantage

Dr. Shelly Gupta Brings Over a Decade of Medicare Advantage and Healthcare Leadership Experience Dr. Shelly Gupta Brings Over a Decade of Medicare Advantage and Healthcare Leadership Experience

4 months ago - GlobeNewsWire

Clover Health: Expected Margin Contraction Is A Prelude To Exponential Growth

Clover Health Investments' AI capabilities are a major driver for its topline and bottom-line improvements in FY 2024. Clover Health's MCR in Q4 represented a decline from Q3, unlike past years, and r...

5 months ago - Seeking Alpha

Counterpart Health Partners with Google Cloud to Improve Clinical Data Access for Physicians

New functionality within Counterpart Assistant uses Google Cloud's Vertex AI Search to give clinicians comprehensive insights across multiple sources of patient health data New functionality within Co...

5 months ago - GlobeNewsWire

Clover Health Investments, Corp. (CLOV) Q4 2024 Earnings Call Transcript

Clover Health Investments, Corp. (NASDAQ:CLOV) Q4 2024 Earnings Conference Call February 27, 2025 5:00 PM ET Company Participants Ryan Schmidt - Investor Relations Andrew Toy - Chief Executive Office...

5 months ago - Seeking Alpha

Clover Health Reports Fourth Quarter and Full Year 2024 Results; Provides Full Year 2025 Guidance

Full year 2024 GAAP Net loss from continuing operations improves by $164 million year-over-year Full year 2024 Adjusted EBITDA of $70 million, representing an increase of $112 million year-over-year C...

5 months ago - GlobeNewsWire

Clover Health to Report Fourth Quarter and Full Year 2024 Financial Results on February 27, 2025

WILMINGTON, Del., Feb. 18, 2025 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover Health”), today announced that it will report fourth quarter and full year 2024 financial r...

6 months ago - GlobeNewsWire